Invited State of the Art Review for MCP Rethinking Obesity Beyond Body Mass Index: A Review of Body Composition and Chronic Disease Risk
Listen to this summary
The authors aim to evaluate the limitations of body mass index (BMI) in diagnosing obesity and assessing chronic disease risk, emphasizing the need for more accurate body composition (BC) metrics. They highlight that BMI fails to account for individual variations in fat distribution and lean mass, which can lead to misclassification of health risks. The review advocates for a transition to BC-based evaluations to enhance obesity diagnosis and improve health outcomes.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Mayo Clinic proceedings
View all →Jun 24, 2026 · Mayo Clinic proceedings
Evaluation of the Preclinical and Clinical Obesity Framework for Risk Stratification of Major Adverse Liver Outcomes
Jun 24, 2026 · Mayo Clinic proceedings
Lumbar Puncture in the 21st Century: an Imaging-Based Primer to Determine Procedural Safety
Jun 24, 2026 · Mayo Clinic proceedings
Association of Obesity With Mortality and Bleeding in Cancer-Associated Venous Thromboembolism
Jun 23, 2026 · Mayo Clinic proceedings
The Physiological Basis of Acute GFR Decline With Renoprotective Therapies
Jun 22, 2026 · Mayo Clinic proceedings
Estimating the Cost of Poor Work Control Among Physicians in the United States
Jun 19, 2026 · Mayo Clinic proceedings
Association Between Angiotensin Receptor Blocker Use and Cardiovascular Outcomes Compared With Angiotensin-Converting Enzyme Inhibitors in Patients With Atherosclerotic Cardiovascular Disease: A Real-World Cohort Study
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
